Correlation Between BioNTech and ATRYS HEALTH

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BioNTech and ATRYS HEALTH at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioNTech and ATRYS HEALTH into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioNTech SE and ATRYS HEALTH SA, you can compare the effects of market volatilities on BioNTech and ATRYS HEALTH and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioNTech with a short position of ATRYS HEALTH. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioNTech and ATRYS HEALTH.

Diversification Opportunities for BioNTech and ATRYS HEALTH

-0.06
  Correlation Coefficient

Good diversification

The 3 months correlation between BioNTech and ATRYS is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding BioNTech SE and ATRYS HEALTH SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ATRYS HEALTH SA and BioNTech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioNTech SE are associated (or correlated) with ATRYS HEALTH. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ATRYS HEALTH SA has no effect on the direction of BioNTech i.e., BioNTech and ATRYS HEALTH go up and down completely randomly.

Pair Corralation between BioNTech and ATRYS HEALTH

Assuming the 90 days trading horizon BioNTech SE is expected to generate 1.91 times more return on investment than ATRYS HEALTH. However, BioNTech is 1.91 times more volatile than ATRYS HEALTH SA. It trades about 0.08 of its potential returns per unit of risk. ATRYS HEALTH SA is currently generating about -0.08 per unit of risk. If you would invest  9,400  in BioNTech SE on September 12, 2024 and sell it today you would earn a total of  1,590  from holding BioNTech SE or generate 16.91% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

BioNTech SE  vs.  ATRYS HEALTH SA

 Performance 
       Timeline  
BioNTech SE 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in BioNTech SE are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, BioNTech reported solid returns over the last few months and may actually be approaching a breakup point.
ATRYS HEALTH SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ATRYS HEALTH SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

BioNTech and ATRYS HEALTH Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BioNTech and ATRYS HEALTH

The main advantage of trading using opposite BioNTech and ATRYS HEALTH positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioNTech position performs unexpectedly, ATRYS HEALTH can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ATRYS HEALTH will offset losses from the drop in ATRYS HEALTH's long position.
The idea behind BioNTech SE and ATRYS HEALTH SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Complementary Tools

Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Share Portfolio
Track or share privately all of your investments from the convenience of any device